PYK2 gene silencing determined a reduction in MM cell proliferation, adhesion, and cell-cycle progression by suppressing Wnt/β-catenin signaling; additionally, RNA interference targeting PYK2 decreased MM tumor growth and stretched the survival time in a xenograft mouse model. The gene discussed is PTK2B; the disease is neoplasm.